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Summary
The B lymphoblastoid cell line clone 13 (a subclone of the mutant cell line P3JHR-1) has been
found to express high levels ofHLADQ; by contrast, HLADR and -DP antigens are not expressed
and cannot be induced by interferony . Northern blot analysis using gene-specific probes indicated
that the lack of surface expression of the DR and DP antigens is due to a marked decrease in
the levels of steady-stateRNA for both the a and # chains. Southern blots demonstrated- that
none of the transcriptionally repressed genes are grossly deleted. Preparation ofinterspecific transient
heterokaryons between clone 13 and the class II antigen-positive murineB cell lymphoma, A20,
resulted in reactivation ofthe DRA gene and surface expression ofboth theDR and DP molecules.
The efficiency of theDRA promoter relative to the DQB promoter is markedly and specifically
diminished in clone 13 (P3JHR-1) as compared with the parental cell line, Jijoye, as assayed both
by transient expression of appropriate chloramphenicol acetyltransferase gene (CAT) constructs
and by in vitro transcription analysis. These data clearly demonstrate the existence of an isotype-
specific traps-acting factor, and provide direct evidence that the highly homologous class II genes
have distinct regulatory mechanisms.
mmune responsiveness to foreign antigen is controlled by
a set of heterodimeric integral glycoproteins encoded within
the class II region of theMHC (1) . These class II molecules
participate in the immune response at two levels : in the se-
lection of the T lymphocyte repertoire in the thymus, and
in the presentation of foreign antigens to T lymphocytes in
the periphery (2) . The molecular basis ofimmune recogni-
tion at both levels is suggested by the hypothetical three-
dimensional structure of the class II molecule, inferred from
the structure of the class I molecule, HLAA2 (3, 4) . A for-
eign antigen binding cleft is predicted to be formed between
the COOH-terminal cx helices of the first al and 01 do-
mains of the a and a polypeptides that form the molecule,
with the floor of the cleft formed by the NH2-terminal /3
strands . Immune recognition, then, involves the discrimina-
tion by T lymphocytes ofclass II molecules that have bound
foreign antigen from those molecules that harbor selfpeptides .
In view of the central role the class II molecules play in
the immune response, it is not surprising that dysregulation
of their tissue-specific and developmental patterns of expres-
sion results in severe impairment of the immune system and
the homeostasis of the organism . Normally, class II mole-
cules are expressed only on cells of the immune system, al-
though they are inducible onmany cells by certain lymphokines
such as IFN-y or 11,4 . The complete loss of class II gene
expression in man results in a severe combined immuno-
deficiency syndrome termed bare lymphocyte syndrome (5),
and the aberrant expression ofclass II molecules on normally
class II-negative cells is hypothesized to trigger or exacer-
bate certain types of autoimmune disease (6) . The elucida-
tion of class II gene regulation, then,, is not only of interest
from the standpoint of eukaryotic transcription, but is sig-
nificant in view of the consequences that defective class II
gene regulation has on the functioning oftheimmune system .
Rapid progress in our understanding ofclass II gene regu-
lation has occurred in the past few years. Comparison of the
5' flanking regions of all of the class II genes analyzed to
date reveal several conserved motifs, most notably, the X and
Y boxes of the proximal promoter (-180 to +10) (7, 8) .
Deletion and mutational analysis have demonstrated that these
motifs are indispensable for class II gene expression, and some
of the genes encoding sequence-specific DNA binding pro-
teins that bind to these motifs in gel retardation and foot-
printing assays have been cloned (9) . In spite of this progress,
several basic questions regarding class II gene regulation re-
main unsolved . For example, are the seven functional class
II genes (Fig . 1 C) that are encoded over a region 1 megabase
in size regulated by the same or distinct mechanisms? The
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expression of the three class II isotypes in man (both tissue
specifically anddevelopmentally), are clues that there is likely
overlap in the transcription factors that regulate the various
genes . Further evidence comes from severalmutant cell lines,
where defects in trans-acting factors affect the expression of
all of the class II genes (10, 11) . On theother hand, gel retarda-
tion analysis suggests that different factors bind theconserved
motifs in the various genes, and differential inducibility of
the class II isotypes on HeLa cells, melanoma lines, and dermal
fibroblastsby IFN-yhas been observed (12-14). In addition,
some cell lines derived from patients with bare lymphocyte
syndrome, certainleukemic cells, and a subset of normal cells
of themyelomonocytic lineage exhibit differential expression
of class II isotypes ; i.e ., they expressHLADR and -DP, but
not-DQ (which is normally expressed at a low level relative
to DR) (15) .
In this report, a B lymphoblastoid cell line (B-LCL),'
clone13 (a subclone of themutant B cell line, P3JHR1) that
exhibits the reciprocal differential expression of the class II
isotypes is described; i.e., it expressesHLADQ, butnot -DR
or -DP and is the first such line reported . Interspecific het-
erokaryons and transient transfection ofreporter plasmids dem-
onstrate that the defect in clone 13 affects an isotype-specific
trans-acting factor, clearly illustrating that theregulatoryma-
chinery for the genes are distinct . The existence of thewild-
type parental line, Jijoye, provides a new isogenic cell pair
with a novel mutant phenotype for the dissection of class
II gene regulation.
Materials and Methods
Cell Lines.
￿
Raji, RJ 2.2.5, A20, Jijoye, andclone 13 cells were
all maintained in RPMI 1640 supplemented with 10% heat-
inactivated FCS, 20 mM Hepes, 5 x 10 3 U/100 ml penicillin and
streptomycin, 2mM glutamine, and1mM sodium pyruvate.The
cells were split1:5 every3 d . Hela cells were maintained inDMEM
media . A20 is a class II-positive marine hybridoma. RJ 2.2.5 is
derivedfrom the Burkitt'slymphoma cell line Raji (DR3, DR10)
after irradiation and immunoselection with class II-specific mAbs
and complement . Raji cells express all three class II isotypes, while
RJ 2.2.5 cells do not express any class II antigen. Jijoye cells (also
originally from a Burkitt'slymphoma patient) were originally iso-
lated by Pulvertaft and designated then as P3 . Jijoye cells also ex-
press all three class II isotypes. Hinuma et al . (16) then isolated
subdones ofthe line in semisolidmediaandgenerateda line desig-
nated PJ-HR-1, which is a high producer of viral capsid antigen .
Clone 13 cells were derived by further subdoning of the Pj HR-1
cell line with the aimofproducing isogenic cell lines with varying
efficiencies of conversion from the latent to lytic cycles ofthe virus
(17) . TheHLA phenotype of the clone 13 cell line is the focus
of this report .
Cell Fusion .
￿
107 cells of each type were combined in a 50-ml
centrifuge tube and washed three times with serum-free media .
The cells were then disaggregatedby passage through an 18-gauge
needle (three times), washed one more time in serum-free media,
and pelleted bygentle centrifugation . The cell pellet wasresuspended
by tappingandwarmed to 37°C.1 ml ofPEG 1500 (50% [wt/volt,
'Abbreviation used in this paper . B-LCL, B lymphoblastoid cell line.
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Boehringer Mannheim Biochemicals, Indianapolis, IN) was added
dropwise over a1-min period . 50 ml ofserum-free media wasthen
added slowly over a3-min period . After allowing the cell suspen-
sion to sit at room temperature for 5 min, the fused cells were
collectedby centrifugation at 250g for3min . 50 ml ofprewarmed
complete media was then added to the cell pellet (resuspending
by gentle tapping) and the cells were incubated at 37°C for 48 h
before they were analyzed.
mAbs and Fluorescence Microscopy.
￿
The following mAbs were
used for immunofluorescence microscopy:LB3.1 (anti-DR), B7/21
(anti-DP), and Genox 3.53 (anti-DQ) . The three mAbs used for
FRCS® analysis (Becton Dickinson&Co., Mountain View, CA)
of cell surface class II expression (LB3.1, Genox 3.53 and Leu-10
[anti-DQ], and B7/21) were all of the IgG1 subclass . Fused cells
were washed gently with PBS and incubated with monospecific
antibody for30 minon ice.The cells were then washed twice with
PBS andincubated with FITC-conjugated goat anti-mouse anti-
body. After washing twicewith PBS, the cells were immediately
analyzed under a fluorescence microscope at the appropriate wave-
length .
Preparation ofTotal CellularRNAandHigh Molecular WeightDNA
and Southern and Northern Blot Analysis. High molecular weight
DNA was isolated by Sarcosyl disruption of the cell membranes
followed by three phenol, twophenol/chloroform, an one chloro-
form extraction . Purified DNA was dialyzed with four changes
against 10 mM Tris(pH8.0) and 1mMEDTA . Total cellularRNA
was isolated after disruption of the cells with 6M guanidium
isothiocyanate, 5 mM NaCitrate (pH 7.0), 0.1 M 0-mercapto-
ethanol, and 0.5% Sarcosyl . RNAwas purified by centrifugation
through a 1.2-ml cushion of 5.7M CsCl at 35,000 rpm for 12 h
at room temperature . The pelletedRNAwas extracted several times
with 4:1 chloroform/butanol and ethanol precipitated and stored
at -70°Cbefore use. 10 jug of high molecularweightDNA was
digested overnight with fivefold excess restriction endonuclease,
phenol-extracted, and ethanol precipitated before separation on1%
agarose gels in 1x TAEbuffer. After visualization on an ultraviolet
transilluminator the gels were denaturedand neutralized and trans-
ferred to GeneScreen Plus hybridization membranes according to
the manufacturers suggested protocols (DuPontCo., Wilmington,
DE). Total cellularRNAwas separated on 1% formaldehyde agarose
gels and transferredto GeneScreen Plus membranes as recommended .
Both Northern andSouthernblots were prehybridized, hybridized,
and washed as recommended.
Plasmids and Nucleic Acid Probes.
￿
For Northern blot analysis,
shortDNA fragments corresponding to divergent regions of the
mRNA were used for specific detection of transcripts.These frag-
ments were derived from SP72 subdones constructed in this labo-
ratory (18) . The precise fragments that were random hexamer la-
beled to generate specific probes were DPA (Bgl 2-Pst), DPB
(Sst-Hae III), DQA (Pst-Pst), DQB (PvuII-PvuII), DRA (Sst-
EcoRI), andDRB (HindIII-Rsa) . Class I heavy chain transcripts
were detected using the Pst fragment of pHLA2. For CAT assay,
the plasmids used were DQB160CAT (19) and DRA1028CAT,
DRA3000AT, andDRA141CAT(20) . ForSouthern blot analysis,
full-length cDNAs were labeled by the random hexamer method .
DRA andDRB cDNAs were kindly donated byD . Monos, Har-
vard University (Monos et al., manuscript in preparation) andthe
DPA and DPB cDNAswere kindly provided byD. Kappes (Har-
vard University) . ThecDNAs were excised from vector sequences
and purified by binding to glass beads before labeling .
Immunoisolation ofHLA Antigens.
￿
Class II antigens were iso-
lated using the modified solid-phase immunoisolation technique .
Briefly, mAbs were immobilized to the surface of 96 U-bottomedPlastic microplates (Falcon Labware, Oxnard, CA) via goat
anti-mouse antibody. After washing, 1% Triton X-100 lysate of
surface iodinated cells (cells were labeled by lactopeoxidase-catalyzed
method) containing 1 mM PMSF was applied, incubated at 4°C
overnight, and washed with lysis buffer and PBS. HLA antigens
bound to theimmobilized mAbs were eluted with reducing sample
buffer and boiled before SDS-PAGE in the discontinuous buffer
system.
Transient Tansfection ofPlasmid DNA and CAT Assay.
￿
101 re-
cipient cells were washed extensively with serum-free media. 20 NAg
of cesium-chloride-purified, supercoiled plasmidDNA was added
to the cells in a 1-ml volume ofserum-freeRPMI 1640 containing
either 20 tal of lipofectin or 200 lAg ofDEAE Dextran (Bethesda
Research Laboratories, Bethesda, MD, and Pharmacia Fine Chem-
icals, Piscataway, NJ, respectively) . 5 pg ofplasmid pXGH5, amam-
malian expression vector encoding human growth hormone, was
cotransfected with reporter constructs to control for variability in
transfection efficiency. In the case oflipofection, cells were incubated
for 3 h at 37°C before addition of 50 ml complete medium . For
DEAE Dextran transfection, the cells were incubated for 1 h at
37°C before addition ofmedium . 48 h after transfection, the cells
were washed with serum-free media and pelleted. The cells were
resuspended in 300 pl of0.25M Tris and freeze-thawed three times .
After centrifugation in a microfuge to remove debris, 150 IAI of
the cell extract was incubated with 20 141 10mM acetyl coenzyme
A (Pharmacia Fine Chemicals) and 2 IAI of '°C-chloramphenicol
(New England Nuclear, Boston,MA) (49 mCi/mmole, 0.1 mCi/ml)
for 4 h at 37°C. The chloramphenicol was then extracted with
1 ml of ethyl acetate, speed vacuum dried, and spotted onto thin-
layer chromatography plates . After the solvent front was allowed
to travel three-quarters of the length of the plate, the plate was
removed from the chromatography tank, allowed to dry, and sub-
jected to autoradiography .
Preparation ofNuclear Extracts, Gel Retardation, and In Vitro Tran-
scription Analysis. 500 ml oflog phase cells was pelleted at 2,000
rpm for 10 min . The cell pellet was washed twice in ice-coldPBS
and resuspended in 25 ml nuclear isolation buffer I (10mM Tris-
HC1, pH 7.9, 10mM KCI, 1.5 mM MgC12, and 1 mM DTT) .
0.3 ml ofice-cold10% NP-40 was added dropwise (while vortexing
at lowest setting) and incubated on ice for 20 min . The cell lysate
was layered onto 12 ml of ice-cold nuclear isolation buffer I con-
taining 1.7M sucrose and centrifuged at 13,000 g for 15 minutes
in an SW27 rotor (Beckman Instruments, Inc., Palo Alto, CA) .
Purified nuclei were then resuspended in 3 ml of ice-cold 20mM
Hepes, pH 7.9, 25% glycerol, 0.42 M NaCl, 1.5mM MgC12, 0.2
mM EDTA, 0.5 mM PMSF, and 0.5mM DTT, and homogenized
with 10 strokes of a dounce homogenizer on ice. The suspension
was then rocked for 30 min at 4°C and centrifuged for 30 min
at 25,000 g in an SS34 rotor . The supernatant was then dialyzed
against 150 ml of transcription buffer (-rNTPs) : 12 mM Hepes,
pH 7.9, 12% glycerol, 0.3mM DTT, 0.12 mM EDTA, and 60
mM KCl for 5 h . M9C12 was omitted from these preparations to
be used for gel-retardation assay, as MgC12 has been found to in-
hibit gel-retardation . For the gel-retardation assay, complementary
oligonucleotides (described in Fig. 6 A) were annealed by boiling
for 2 min in 0.5 M NaCl, 20 mM Tris-Cl, pH 7.5, and 1 mM
EDTA, followed by incubation overnight at 65 °C. The oligonu-
cleotides were then ethanol precipitated and gelpurified . The double-
stranded oligonucleotides were then labeled by polynucleotide kinase
and separated from unincorporated 32P by spun-column chroma-
tography on Biogel P-2 . DNA binding was allowed to proceed for
20 min at room temperature in a 10-p,1 volume containing 5 jug
nuclear extract and 5,000 cpm radiolabeled oligonucleotide in the
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presence of 4 jug poly(dL)dC (in a buffer containing 10 mM Tris,
pH 7.5, 50mM NaCl, ImMDTT,1mM EDTA, and5% glycerol) .
The protein-DNA complexes were then resolved from freeDNA
by separation on a 5% polyacrylamide gel . The products were then
visualized by autoradiography of the fixed, dried gel . For in vitro
transcription analysis, 25 ul of nuclear extract was added to 1 IAI
templateDNA (SmaIF-cleaved pSma1F fragment of the adenovirus
major late promotor and Ddel-cleavedDRA1028CAT orDQB2500
CAT plasmids) and incubated at room temperature for 30 min to
allow preinitiation complex formation . 10 pl of 10x rNTP solu-
tion was added to preinitiation complexes : 6mM ATP, CTP, UTP,
and 2 Al of 250 juM a-[32]P-GTP Transcription buffer was then
added to a final volume of 50 Fd . Transcription was then allowed
to proceed for 2 h at 30°C. Nucleic acids were purified by sequen-
tial phenol, phenol/chloroform, and chloroform/isoamyl alcohol
extractions, and precipitated by addition of 50 pl 10.5 M ammo-
nium acetate, pH 5.2, 1% SDS, 1 Ftg tRNA, and 250 IAI ice-cold
ethanol . After precipitation and washing with 70% ethanol, the
RNA was heated to 68°C for 5 min and loaded onto a4% acryl-
amide gel containing 7M urea. The gel was then fixed in 10%
acetic acid, 10% methanol, dried for 1 h at 90°C, and autoradio-
graphed .
Results
HLA Phenotype of Clone 13 and its Related Cell Lines.
During studies of the inducibility of class II genes, clone 13
cells (a subclone of the mutant EBVtransformed cell line,
P3JHR-1, whose parent was the Burkitt's lymphoma cell line
Jijoye) were found to express very high levels of surface HLA-
DQ and class I antigens but notHLA-DR or HLA-DP (Fig.
1 A) . P+HR-1, which had been derived without mutagen-
esis by plating Jijoye in semisolid media and screening for
a high producer of EBV viral capsid antigen, had the same
phenotype. By contrast, the original Burkitt's lymphoma iso-
late, Jijoye, expressed all three class II molecules . Analysis of
several other B-LCLs by FRCS analysis indicates that the level
of cell surface expression ofHLADQ on clone 13 was com-
parable with that on other B-LCLs examined . Both Leu-10
and Genox antibodies were used to detectHLADQbyFRCS
analysis, and both indicated that high levels ofHLADQ are
expressed on the surface of clone 13 cells . Expression of
HLADQ on the surface of clone 13 was demonstrated une-
quivocally by immunoaffinity isolation ofthe molecule from
surface-iodinated clone 13 cells with the anti-HLADQ anti-
body BT3/4 (Fig. 1 B) . Using a panel of mAbs that recog-
nize different DQ alleles, the molecule expressed on clone
13 cells was shown to be DQ1 (data not shown) .
Marked Reduction in the Transcription of the a and a Chain
Genes ofHLA-DR and-DP in Clone 13 in the Absence ofGross
Deletion ofthe Structural Genes. The level at which expres-
sion ofHLADR and -DP antigens is blocked in clone 13
cells was investigated by Northern blot analysis using gene-
specific probes derived from the divergent 3' untranslated
regions of the various genes. TheDRA andDRB genes, as
well as DPA and DPB, were transcribed at high levels inJijoye
and Raji cells, while transcripts for all four genes were unde-
tectable in clone 13 andRJ2.2.5 cells (a class II-negativemu-
tant of Raji) (Fig. 2) . In contrast, the DQA and DQB genes
were transcribed at high levels in Jijoye clone 13 and Raji .cosmid cloning of the different loci . The transcriptional orientation of the genes is indicated by arrows.
containing the class I, III, TNF, and newly identified genes are located in the direction of the large arrow.
Class I genes were also transcribed in all of the cells . To de-
termine whether the decreased transcription of the ci and /3
chain genes ofHLADR and -DP in clone 13 cells resulted
from gross deletion of any of the genes. Southern blot anal-
ysis was next performed using full-length cDNAs as probes.
None of the genes examined was grossly deleted in any of
the cells (Fig. 3) . Although some of these genes exhibit re-
striction fragment length polymorphism, the isogenic cell
pairs, Jijoye-clone 13 and Raji-RJ2.2.5, had identical RFLP
patterns.
Preparation ofInterspecfic Transient Heterokaryvns between Clone
13 and the Class II-Positive Murine Hybridoma A20 Activates
de novo Expression ofHLA-DR and -DP Antigens. Transient
fusion of cells from different species has been used to demon-
strate the existence of trans-acting factors in several systems
(21) . Transient interspecific clone 13 x A20 heterokaryons
were prepared by fusion with polyethylene glycol (PEG) (see
Materials and Methods) . 48 h after cell fusion, cell surface
expression ofHLADR and -DP antigens was assessed by
immunofluorescence microscopy using themAbsLB3.1 and
B7/21, respectively, followedby FITC-conjugated IgG as the
fluorochrome. Transient homokaryons, clone 13 x clone 13
andA20 x A20, prepared in parallel served as controls . Nei-
ther the clone 13 norA20 transient homokaryons expressed
HLADR or -DP antigen on their cell surface (and moreover,
the mAbs LB3.1 and B7/21 do not crossreact with the mu-
rine class II molecules I-A and I-E expressed on the surface
of A20) (Fig . 4) . The interspecific transient heterokaryon be-
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Figure 1 .
￿
(A) Cell surfaceexpression
of the HLA molecules on Jijoye and
clone 13 . (A) FACS analysis of cell sur-
face expression of class I (W6/32),
HLA-DR (LB 3 .1), HLA-DQ (Genox
3.53), and HLA-DP (B7/21) on Daudi,
Jijoye, and clone 13 cells. The same
results wereobtained with the anti-DQ
mAb Leu-10 . All antibodies were ofthe
IgG subclass . (B) Immunoisolation of
HLA antigens from surface iodinated
Jijoye (lanes 1-4) and clone 13 (lanes
5-8) cells using mAbs L243 (anti-DR ;
lanes 1 and 5), BT3/4 (anti-DQ; lanes
2 and 6), B7/21 (anti-DP, lanes 3 and
7), and MEM-18 as a negative control
(anti-CD14 ; lanes 4 and 8) . Isolated an-
tigens were separated by SDS-PAGE and
subjected to autoradiography. Position
ofHLA antigens is indicated . The differ-
ence in intensity of bands in lanes 1-4
as compared with lanes 5-8 is due
to different extent oflabeling of the cells
in the two experiments and to different
times of exposure of the autoradio-
grams . (C) Organization ofthe HLA-D
(class II) region genes in the human
MHC . The linkage map was generated
by pulsed-field gel electrophoresis and
The remaining 2 .5 megabases of theMHC
tween clone 13 and A20, however, expressed bothHLA-DR
and -DP antigen de novo. To show unequivocally that tran-
scription of a previously silent human class II gene was acti-
vated by fusion with A20, total cellular RNA was isolated
from both homokaryons and the interspecific heterokaryon
48 h after fusion and analyzed by Northern blotting . Tran-
scripts from the DRA gene were undetectable in total cel-
lularRNA from clone 13, from A20, and from the A20 and
clone 13 homokaryons.DRA transcripts were detected, how-
ever, inRNA isolated from the clone 13 x A20 heterokaryons
(Fig . 5) .
Transient Tansfection of CAT Constructs and In Vitro Tran-
scription Analysis Provide Additional Evidence ofan Isotype-speck
Trans-activator Defect in Clone 13 . To examine further the defect
in HLA-DR expression in clone-13 cells, CAT constructs
bearing progressive 5' deletions (-1028, -300, and -141
by of upstream sequence) of the DRA promoter or 160
by of upstream sequence from theDQB gel were transfected
into clone 13 andJijoye cells (Fig . 6A) . All of the CAT con-
structs were transcribed efficiently in Jijoye cells . Transfec-
tion of theDQB160CAT plasmid into clone 13 cells resulted
in the expression of comparable levels ofCAT activity . with
that observedwhen transfected into Jijoye cells . On the other
hand, transfection ofany of theDRACAT plasmids into clone
13 cells resulted in only 5% of the CAT activity observed
in Jijoye cells. In vitro transcription analysis using two different
nuclear extract preparations from Jijoye and clone 13 indi-
cated that DRACAT transcription could not be supportedFigure 2 . Transcription of the various
HLA genes in Jijoye, clone 13, Raji, and
RJ2 .2 .5 cells. 10 ug of total RNA isolated
from each cell line was separated on formal-
dehyde gels, transferred to GeneScreen Plus
hybridization membranes, and probed with
random-hexamer-primed, rediolabeled probes
specific for the indicated transcripts. The
Northern blots were then washed at high
stringency and the resulting autoradiograms
are presented .
633
￿
Ono et al .
Figure3 .
￿
Genomic Southernblotsofhigh molecularweightDNA iso-
lated from the cell linesJijoye, clone 13, Raji, and RJ2 .2 .5 . 20 wg ofgenomic
DNA isolated from the various cell lines was cleaved by overnight diges-
tion with the indicated restriction endonucleases. The cleavedDNA was
then separated on1% agarose gels, transferred to GeneScreen Plus hybrid-
ization membranes, and probed with random hexamer-primed, radiola-
beled cDNAs ofthe indicated genes . After high stringency washing, the
filters were exposed to X-ray film, and the autoradiograms are presented .
Figure 4.
￿
Interspecific transient het-
erokaryons between clone 13 and A20
cells express HLA-DR and -DP mole-
cules de novo on theircell surface . 48 h
after fusion with PEG 1500, clone 13
and A20 homokaryons and clone 13 x
A20 heterokaryons were assayed for ex-
pression ofHLA-DR and -DP antigens
using LB3.1 and B7/21 (respectively)
mAbs as primaryantibody. FITC-con-
jugated goat anti-mouse immunoglob-
ulin was used as secondary antibody.
After gently washing, the homokaryon
and heterokaryon preparations wereana-
lyzed under an immunofluorescence nu-
croscope and both phase/contrast and
immunofluorescent photographs were
taken . Phase/contrast and immuno-
fluorescence photographs oftransiently
fused cells from the clone 13 and A20
homokaryon fusions and the clone 13 x
A20 heterokaryon fusion arepresented.Figure 5 .
￿
TheDRA gene is activated de novo in the clone 13 x A20
heterokaryon . 10 ug of total RNA isolated from the indicated cell lines
and from the indicated fusions (48 h after fusion) was fractionated on a
formaldehyde gel . After transfer to a nylon membrane, the Northern blot
was first probed with the radiolabeled DRA-specificfragment . After high
stringency washing* the Northern blot was exposed to X-ray film . After
exposurefor 3 d, the same filter was strippedof theDRA probe by boiling
in distilled water, and reprobed with they-actin-specificprobe. After high
stringency washing, the blot was exposed to X-ray film for 4 h . The au-
toradiograms are presented . The fusion efficiency of-10% accounts for
the relatively low level of DRA mRNA in the heterokaryon .
in clone 13 nuclear extract (in contrast to Jijoye nuclear ex-
tract), while DQBCAT transcription was transcribed with
equal efficiency in Jijoye and clone 13 extracts (Fig. 6 B) .
Gel Retardation Assays Using Oligonucleotides Spanning the
Proximal Promoter oftheDRA Gene RevealNo Detectable Dt$er-
ences in Sequence-specificDNA Binding in Nuclear Extractsfrom
Jyoye and Clone 13 Cells.,
￿
Since only 141 by ofupstream se-
quence are sufficient for efficient activity of the DRA pro-
motor in B-cells (Fig. 6 A), gel retardation assays using oli-
gonucleotides spanning this region were performed in an
attempt to identify whether the putative defective transacti-
vator might bind to this proximal promoter. However, no
differences inDNA binding were detectable in nuclear ex-
tracts prepared from Jijoye and from clone 13 cells using the
three oligonucleotides DRAS, DRAX, and DRAY+OCT,
which cover the region from -37 to -143 (Fig . 7) .
Treatment with IFN-7 Is Unable to Induce the Expression of
HLA-DR or-DPAntigens on Clone 13 Cells. IFN-y can in-
duce the expression of class II molecules on many cell types
that are normally class II negative. To test whether the defect
in HLA-DR and -DP expression in cells could be bypassed
after treatment with IFN-y, clone 13 (as well as HeLa cells,
which are normally class II negative as a positive control)
was incubated in the presence of 400 U/ml human rIFN-y
for 48 h . IFN-y treatment induced low-levelHLADR and
-DP (but not -DQ expression on HeLa cells, but did not
induce the expression of any class II isotype on clone 13 cells
(Fig. 8) .
Figure 6.
￿
(A) Assay ofCAT activity in extracts from Jiyoye and clone 13 cells transiently transfected with the DQB160CAT and three DRACAT
reporter plasmids. Cell extracts were incubated with C 14-chloramphenicol, as described in Materials and Methods, and the ethyl acetate-extracted ma-
terial was separated on TLC . The autoradiogram of the dried TLC plate is presented . CAT activity was measured by counting the radioactivity of
excised portions of the TLC plate corresponding to the amtylated form of chloramphenicol (3-acetate chloramphenicol). (B) In vitro transcription
of the DRA1028CAT and DQB25000AT plasmids in two different nuclear extract preparations from Jijoye and clone 13 cells. MLP indicates the
in vitro transcript from the adenovirus major late promoter, and DRA andDQB the in vitro transcripts generated from the linearizedCAT plasmids.
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The class II region of theMHC of all vertebrates studied
to date contain multiple genes that encode the cx andß chain
polypeptides that cdnstitute a class II heterodimer. The iso-
lation and sequence analysis ofthe genes encoding thesepoly-
peptides facilitated the identification of conserved cis-acting
elements in the proximal-promoters of these genes. Three
elements, called W, X, and Y boxes, are found in all class
II genes . The similarities of the proximal promoters of the
class II genes has been interpreted by some to suggest that
the members ofthe class II multigene family are coordinately
regulated (22) . Further support for this hypothesis has come
from the analysis of several mutant cell lines, where defects
in the class II transcription machinery have generally affected
the expression of all of the class II genes . On the other hand,
cell lines that express DR and DP without DQ have been
reported . Three reports indicate that the different class II iso-
types are activated at different times in cell differentiation
(23-25), and the fourth (15) indicates that an extremely low
level ofDQA transcription occurs in a cell line isolated from
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Figure 7 .
￿
Gel-retardation analysis of
nuclear extracts prepared from HeLa,
Jijoye, and clone 13 cells using overlap-
ping probes from the DRA proximal
promoter. (A) The nucleotide sequence
of theDRA proximal promoter with
the conserved cis-actingmotifsW-box,
X-box, Y -box, and the octamer con-
sensus sequence are boxed. The precise
nucleotides contained in the indicated
oligonucleotides are: W-box (5'GTA-
TCTTGTGTCCTGGACCCTTTG-
CAAGAACCCTTC3'), X-box (5'AG
AACCCTTCCCCTAGCAACAGAT
GCGTCATCTCAAAATATT3'), and
Ybox + octamer (5'TCTCAAAAT
ATTTTTCTGATTGGCCAAAGAG
TAATGATTTGCATTTTAAT3') . (B)
Autoradiograms ofprotein-DNA com-
plexes and free radiolabeled oligonucle-
otide after incubation of the indicated
double-stranded oligonucleotide with
the indicated nuclear extract .
Figure 8 .
￿
FACS analysis of the cell surface expres-
sion ofHLA antigenson Hela and clone 13 cells with
and without treatment with 400 U/ml rIFN--f for
48 h . The same mAbs used in Fig . l were used in these
experiments .
a patient with bare lymphocyte syndrome (BLS-1) . Further
clues that the class II genes may not be coordinately regu-
lated come from crosscompetition experiments where syn-
thetic oligonucleotides corresponding to the conserved cis-
acting elements from the different genes are analyzed for their
ability to compete with each other in gel retardation assays
(12, 13) . These studies suggest the existence ofmultipleDNA
binding proteins with differential affinity for the conserved
elements in the various genes.
In this report, a B-LCL, clone 13, is described that ex-
presses high levels of the HLA-DQ1 antigen on its cell sur-
face, in the absence of HLA-DR and -DP expression (Fig .
1) . This cell line exhibits a marked reduction in the tran-
scription of the cx and ß chain genes of HLA-DR and -DP
in the absence ofgross deletion of their structural genes (Figs.
2 and 3) . The parental Burkitt's lymphoma line, jijoye, from
which clone 13 was derived, expresses high levels of all three
class 11 isotypes (Fig. 1 A) . Two lines of evidence strongly
suggest that the defect in HLA-DR and -DP expression inclone 13 cells affects an isotype-specific trans-activator. First,
preparation of interspecific transient heterokaryons between
clone 13 and the class II-positive murine hybridoma, A20,
activates the de novo cell surface expression of theHLA-DR
and -DP antigens and the transcription of the DRA gene
(Figs . 4 and 5) . Second, transient transfection and in vitro
transcription analysis of CAT constructs demonstrates that
the DRA promoter is specifically downregulated by themu-
tation in clone 13 (Fig . 6) . The interspecific heterokaryon
results demonstrate that a mouse homologue to the mutant
factor exists, and that this murine homologue is sufficiently
conserved to activate human class II genes.
The expression of high levels ofHLADQ antigen on clone
13 in the face of marked reduction in the transcription of
the genes encoding the HLADR and -DP antigens clearly
demonstrates that the defective transactivator exhibits iso-
type specificity . Three other reports suggest that the regula-
tion ofHLADQ genes might be different from the HLA
DR and -DP genes (15, 18, 23) . Symington et al . (23) found
that DR and DP antigens are sometimes expressed in the
absence ofDQ. Moreover, HLADR and -DP expression can
be induced by IFN-y on certain cell types without the in-
duction ofHLADQ (14, 18, 26) . These results have been
interpreted by some to suggest that trans-activators in addi-
tion to those required for the expression ofHLADR and
-DP are required forHLADQ transcription . Indeed, previous
to this report, the only example of transcription of an HLA-
DQ gene in the absence ofDR or DP transcription was the
detection of a very low level ofDQA transcription in BLS-1
(15) . BLS-1 is quite different from clone 13, however, as the
DQB gene is not expressed and transcription of the DQA
gene is markedly reduced . Clone 13, then, is the first ex-
ample of a cell expressing high levels of surface HLA-DQ
in the absence of HLA-DR and -DP. The clone 13 pheno-
type suggests that HLA-DR and -DP genes require a trans-
activator that is not critical for the transcription of HLA-
DQ genes . Taken together, these data demonstrate that the
class II genes have different regulatory mechanisms .
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